Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 4/2019

19.03.2019 | Original Article

Prevalence and patterns of cardiac autonomic dysfunction in male patients with type 2 diabetes mellitus and chronic Charcot’s neuroarthropathy: a cross-sectional study from South India

verfasst von: Dukhabandhu Naik, Haobam Surjitkumar Singh, Riddhi Das Gupta, Felix Jebasingh, Thomas V. Paul, Nihal Thomas

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Aims

Our study aimed to look at the prevalence and patterns of cardiac autonomic neuropathy related dysfunction in male patients of type 2 diabetes mellitus with chronic Charcot’s foot.

Methods

A total of 74 male patients with type 2 diabetes mellitus were included in this study. Three groups of patients were selected: Group 1 included patients with chronic Charcot’s foot (n = 24), group 2 included patients with diabetic peripheral neuropathy without chronic Charcot’s foot (n = 22) and group 3 included patients without peripheral neuropathy or chronic Charcot’s foot (n = 28). The autonomic functions were tested using a personal computer-based cardiac autonomic neuropathy (CANS-504) analyser.

Results

The combined sympathetic (SNS) and parasympathetic autonomic function (PNS) abnormalities were detected in about 70.8% in the chronic Charcot’s group, 55.6% in the peripheral neuropathy group and 35.7% in the non-neuropathic group. In patients with chronic Charcot’s foot (n = 24), 29.2% had normal, 20.8% had borderline and 50% had abnormal PNS functions, while 4.2% had normal, 16.7% had borderline and 79.2% had abnormal SNS functions. The Meary’s angle (183.18 ± 73.83 vs 157.98 ± 14.11; p < 0.196) and Calcaneal pitch (7.07 ± 3.30 vs 8.5 ± 1.88; p < 0.219) were greater in the subjects with combined autonomic neuropathy, suggesting more structural deformity in them.

Conclusion

Cardiac autonomic neuropathy-related dysfunction was found to be more common in type 2 diabetes patients with chronic Charcot’s foot. This study has highlighted that patients with diabetic mellitus and chronic Charcot’s foot should be screened comprehensively in order to prevent complications related to cardiac autonomic dysfunction.
Literatur
1.
Zurück zum Zitat Wukich D, Sung W, Wipf AM, Armstrong D. The consequences of complacency: managing the effects of unrecognized Charcot feet. Diabet Med. 2011;28:195–8.CrossRef Wukich D, Sung W, Wipf AM, Armstrong D. The consequences of complacency: managing the effects of unrecognized Charcot feet. Diabet Med. 2011;28:195–8.CrossRef
2.
Zurück zum Zitat Botek G, Anderson MA, Taylor R. Charcot neuroarthropathy: an often overlooked complications of diabetes. Cleve Clin J Med. 2010;77(9):593–9.CrossRef Botek G, Anderson MA, Taylor R. Charcot neuroarthropathy: an often overlooked complications of diabetes. Cleve Clin J Med. 2010;77(9):593–9.CrossRef
3.
Zurück zum Zitat Frykberg RG, Mendeszoon E. Management of the diabetic Charcot foot. Diabetes Metab Res Rev. 2000;16:S59–66.CrossRef Frykberg RG, Mendeszoon E. Management of the diabetic Charcot foot. Diabetes Metab Res Rev. 2000;16:S59–66.CrossRef
4.
Zurück zum Zitat Jeffcoate WJ, Lima J, Nobrega L. The Charcot foot. Diabet Med. 2000;17:253–8.CrossRef Jeffcoate WJ, Lima J, Nobrega L. The Charcot foot. Diabet Med. 2000;17:253–8.CrossRef
5.
Zurück zum Zitat Sinha S, Munichoodappa C, Kozak G. Neuro-arthropathy (Charcot joints) in diabetes mellitus. Medicine. 1971;51:191–210.CrossRef Sinha S, Munichoodappa C, Kozak G. Neuro-arthropathy (Charcot joints) in diabetes mellitus. Medicine. 1971;51:191–210.CrossRef
6.
Zurück zum Zitat Armstrong DG, Peters EJ. Charcot’s arthropathy of the foot. J Am Podiatr Med Assoc. 2002;92:390–4.CrossRef Armstrong DG, Peters EJ. Charcot’s arthropathy of the foot. J Am Podiatr Med Assoc. 2002;92:390–4.CrossRef
7.
Zurück zum Zitat Gazis A, Pound N, Macfarlane R, et al. Mortality in patients with diabetic neuropathy osteoarthropathy (Charcot foot). Diabet Med. 2003;21:1243–6.CrossRef Gazis A, Pound N, Macfarlane R, et al. Mortality in patients with diabetic neuropathy osteoarthropathy (Charcot foot). Diabet Med. 2003;21:1243–6.CrossRef
8.
Zurück zum Zitat Fabrin J, Larsen K, Holstein PE. Long term follow up in diabetic Charcot foot with spontaneous onset. Diabetes Care. 2000;23:796–800.CrossRef Fabrin J, Larsen K, Holstein PE. Long term follow up in diabetic Charcot foot with spontaneous onset. Diabetes Care. 2000;23:796–800.CrossRef
9.
Zurück zum Zitat Wukich DK, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complicat. 2009;23:409–26.CrossRef Wukich DK, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complicat. 2009;23:409–26.CrossRef
10.
Zurück zum Zitat Mabilleau G, Petrova NL, Edmonds ME, Sabokbar A. Increased osteoclastic activity in acute Charcot’s osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia. 2008;51:1035–40.CrossRef Mabilleau G, Petrova NL, Edmonds ME, Sabokbar A. Increased osteoclastic activity in acute Charcot’s osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia. 2008;51:1035–40.CrossRef
11.
Zurück zum Zitat Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085–96.CrossRef Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085–96.CrossRef
12.
Zurück zum Zitat Uccioli L, Mancini L, Giordano A, Solini A, Magnani P, Manto A, et al. Lower limb arteio-venous shunts autonomic neuropathy and diabetic foot. Diabetes Res Clin Pract. 1992;16(2):123–30.CrossRef Uccioli L, Mancini L, Giordano A, Solini A, Magnani P, Manto A, et al. Lower limb arteio-venous shunts autonomic neuropathy and diabetic foot. Diabetes Res Clin Pract. 1992;16(2):123–30.CrossRef
13.
Zurück zum Zitat Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care. 1995;18:34–8.CrossRef Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care. 1995;18:34–8.CrossRef
14.
Zurück zum Zitat Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93.CrossRef Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93.CrossRef
15.
Zurück zum Zitat Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Microalbuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421–6.CrossRef Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Microalbuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421–6.CrossRef
16.
Zurück zum Zitat Piha SJ. Cardiovascular responses to various autonomic tests in males and females. Clin Auton Res. 1993;3(1):15–20.CrossRef Piha SJ. Cardiovascular responses to various autonomic tests in males and females. Clin Auton Res. 1993;3(1):15–20.CrossRef
17.
Zurück zum Zitat Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;8:491–8.CrossRef Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;8:491–8.CrossRef
18.
Zurück zum Zitat Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79.CrossRef Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79.CrossRef
19.
Zurück zum Zitat Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J. 1982;285:916–8.CrossRef Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J. 1982;285:916–8.CrossRef
20.
Zurück zum Zitat Jyotsna VP, Sahoo A, Sreenivas V, Deepak KK. Prevalence and pattern of cardiac autonomic dysfunction in newly detected type 2 diabetes mellitus. Diabetes Res Clin Pract. 2009;83:83–8.CrossRef Jyotsna VP, Sahoo A, Sreenivas V, Deepak KK. Prevalence and pattern of cardiac autonomic dysfunction in newly detected type 2 diabetes mellitus. Diabetes Res Clin Pract. 2009;83:83–8.CrossRef
21.
Zurück zum Zitat Petrova N, Foster A, Edmunds M. Difference in presentation of Charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care. 2004;27(5):1235–6.CrossRef Petrova N, Foster A, Edmunds M. Difference in presentation of Charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care. 2004;27(5):1235–6.CrossRef
22.
Zurück zum Zitat Pakarinen T, Laine HJ, Honokonen SE, et al. Charcot arthropathy of the diabetic foot. Current concepts and review of 36 cases. Scand J Surg. 2002;91(2):195–201.CrossRef Pakarinen T, Laine HJ, Honokonen SE, et al. Charcot arthropathy of the diabetic foot. Current concepts and review of 36 cases. Scand J Surg. 2002;91(2):195–201.CrossRef
23.
Zurück zum Zitat Petrova NL, Foster AV, Edmonds ME. Difference in presentation of Charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care. 2004;27:1235–6.CrossRef Petrova NL, Foster AV, Edmonds ME. Difference in presentation of Charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care. 2004;27:1235–6.CrossRef
24.
Zurück zum Zitat Younis BB, Shahid A, Arshad R, Khurshid S, Masood J. Charcot osteoarthropathy in type 2 diabetes persons presenting to specialist diabetes clinic at a tertiary care hospital. BMC Endocr Disord. 2015;15:28.CrossRef Younis BB, Shahid A, Arshad R, Khurshid S, Masood J. Charcot osteoarthropathy in type 2 diabetes persons presenting to specialist diabetes clinic at a tertiary care hospital. BMC Endocr Disord. 2015;15:28.CrossRef
25.
Zurück zum Zitat Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010;33:434–41.CrossRef Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010;33:434–41.CrossRef
26.
Zurück zum Zitat Pfeifer MA, Weinberg CR, Cook DL, Reenan A, Halter JB, Ensinck JW, et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care. 1984;7:447–53.CrossRef Pfeifer MA, Weinberg CR, Cook DL, Reenan A, Halter JB, Ensinck JW, et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care. 1984;7:447–53.CrossRef
27.
Zurück zum Zitat Javorka K, Javorková J, Petrásková M, Tonhajzerová I, Buchanec J, Chromá O. Heart rate variability and cardiovascular tests in young patients with diabetes mellitus type 1. J Pediatr Endocrinol Metab. 1999;12:423–31.CrossRef Javorka K, Javorková J, Petrásková M, Tonhajzerová I, Buchanec J, Chromá O. Heart rate variability and cardiovascular tests in young patients with diabetes mellitus type 1. J Pediatr Endocrinol Metab. 1999;12:423–31.CrossRef
28.
Zurück zum Zitat Pinzur MS. Benchmark analysis of diabetic patients with neuropathic (Charcot) foot deformity. Foot Ankle Int. 1999;20(9):564–7.CrossRef Pinzur MS. Benchmark analysis of diabetic patients with neuropathic (Charcot) foot deformity. Foot Ankle Int. 1999;20(9):564–7.CrossRef
29.
Zurück zum Zitat Stuck RM, Sohn MW, Budiman-Mak E, Lee TA, Weiss KB. Charcot arthropathy risk elevation in the obese diabetic population. Am J Med. 2008;121(11):1008–14.CrossRef Stuck RM, Sohn MW, Budiman-Mak E, Lee TA, Weiss KB. Charcot arthropathy risk elevation in the obese diabetic population. Am J Med. 2008;121(11):1008–14.CrossRef
30.
Zurück zum Zitat Stevens MJ, Edmonds ME, Foster AV, Watkins PJ. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia. 1992;35:148–54.CrossRef Stevens MJ, Edmonds ME, Foster AV, Watkins PJ. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia. 1992;35:148–54.CrossRef
31.
Zurück zum Zitat Jirkovska A, Boucek P, Wu S, Hosova J, Bem R, Fejfarova V, et al. Power spectral analysis of heart rate variability in patients with Charcot’s neuroarthropathy. J Am Podiatr Med Assoc. 2006;96:1–8.CrossRef Jirkovska A, Boucek P, Wu S, Hosova J, Bem R, Fejfarova V, et al. Power spectral analysis of heart rate variability in patients with Charcot’s neuroarthropathy. J Am Podiatr Med Assoc. 2006;96:1–8.CrossRef
32.
Zurück zum Zitat Edmonds ME, Roberts VC, Watkins PJ. Blood flow in the diabetic neuropathic foot. Diabetologia. 1982;22:9–15.CrossRef Edmonds ME, Roberts VC, Watkins PJ. Blood flow in the diabetic neuropathic foot. Diabetologia. 1982;22:9–15.CrossRef
33.
Zurück zum Zitat Koeck FX, Bobrik V, Fassold A, Grifka J, Kessler S, Straub R. Marked loss of sympathetic nerve fibers in chronic Charcot foot of diabetic origin compared to ankle joint osteoarthritis. J Orthop Res. 2009;27(6):736–41.CrossRef Koeck FX, Bobrik V, Fassold A, Grifka J, Kessler S, Straub R. Marked loss of sympathetic nerve fibers in chronic Charcot foot of diabetic origin compared to ankle joint osteoarthritis. J Orthop Res. 2009;27(6):736–41.CrossRef
Metadaten
Titel
Prevalence and patterns of cardiac autonomic dysfunction in male patients with type 2 diabetes mellitus and chronic Charcot’s neuroarthropathy: a cross-sectional study from South India
verfasst von
Dukhabandhu Naik
Haobam Surjitkumar Singh
Riddhi Das Gupta
Felix Jebasingh
Thomas V. Paul
Nihal Thomas
Publikationsdatum
19.03.2019
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 4/2019
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-019-00722-5

Weitere Artikel der Ausgabe 4/2019

International Journal of Diabetes in Developing Countries 4/2019 Zur Ausgabe